Navigation Links
CV Therapeutics Reports Option Grants Under Nasdaq Marketplace Rule 4350
Date:10/26/2007

being developed for potential use as a pharmacologic stress agent in myocardial perfusion imaging studies and CVT-6883, which is being developed as a potential treatment for cardiopulmonary diseases. Regadenoson and CVT-6883 have not been determined by any regulatory authorities to be safe or effective in humans for any use.


'/>"/>
SOURCE CV Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Canadian firm buys Proventiv Therapeutics, makes ex-Bone Care exec CEO
2. TomoTherapy reports 86% revenue jump, $131M net loss in Q1
3. Sonic Foundry reports GAAP loss as Q2 revenues rise
4. Fiserv reports $113.5 million in Q1 profit
5. Third Wave reports net loss of $18.9M for 2006
6. Musicnotes reports 45 percent growth in 2006
7. Sonic Foundry reports net loss, higher revenue
8. Sonic Foundry reports first cash-positive quarter
9. Merge Healthcare reports $10.8M net loss in Q3
10. Third Wave reports $5.2M third quarter loss
11. Merge Healthcare appoints new CEO, reports $215 million Q2 loss

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/4/2009)... This webinar, which will be presented ...g in continuous flow chemistry processing, will de...nline using various meso and micro scale flow chem... publications has been recognized with several pre...y the 2009 Tetrahedron Prize. , ...
(Date:11/4/2009)..., ROCKVILLE, Md., Nov. 4 Zyngenia,...cused on next-generation antibody drug development...in Series A funding from New Enterprise Associates... firms. The capital will be used to create novel, ...s two or more biological targets with a single age...
(Date:11/4/2009)...ITY, Nov. 4 /PRNewswire-FirstCall/ - Medicago Inc....developing highly effective and affordable vaccine...and Virus-Like Particles (VLPs), today announced t...ment of Health and Human Services (HHS) to present... (GHSI) on November 5, 2009 at 2:40 pm (EST) at th...
(Date:11/4/2009)...outh Korea, Nov. 4 RNL B...utical company specialized in adult stem cell ther...an college student who was suffering from autoimmu... two months after treatment. ,, Chloe Sohl, an ... University of Arizona was suffering from autoimmu...
Breaking Biology Technology:Professor Steven Ley of University of Cambridge will Present Free Webinar, 'Application of the ReactIR Flow Cell to Continuous Processing Technology' 2Professor Steven Ley of University of Cambridge will Present Free Webinar, 'Application of the ReactIR Flow Cell to Continuous Processing Technology' 3Zyngenia, Inc. Raises $10 Million in Series A Funding 2Zyngenia, Inc. Raises $10 Million in Series A Funding 3Zyngenia, Inc. Raises $10 Million in Series A Funding 4Medicago to present at the U.S. Department of Health and Human Services' Global Health Security Initiative Workshop 2RNL BIO Rescues a College Student from Autoimmune Hearing Loss 2RNL BIO Rescues a College Student from Autoimmune Hearing Loss 3RNL BIO Rescues a College Student from Autoimmune Hearing Loss 4
..., September 20 EpiStem,(LSE: EHP) announced today... efficacy-testing services for potential biodefens... drug screening programme over the coming,year. T...ntermeasures against,Radiological and Nuclear Thre...elop treatments for radiation sickness following a...
...ecibo plant, St. Jude Medical will add up to 1,200...ons in its second facility in ... 19 St. Jude,Medical, Inc. (NYSE: STJ ) today an...ico. St. Jude Medical recently purchased a facilit... allow the company to increase its,Puerto Rico ope...
...t. 19 Biodel Inc. (Nasdaq:,BIOD) today announced ...-Q,for the quarterly period ended June 30, 2007 to...non-cash share-based compensation expense arising ...rs at the time of the,Company,s initial public off...pensation expense and is solely non-cash in nature...
Other Biology Technology:EpiStem Successfully Complete First Year of Mucositis Tests for NIH Biodefence Programme 2EpiStem Successfully Complete First Year of Mucositis Tests for NIH Biodefence Programme 3St. Jude Medical to Expand Puerto Rico Operations 2Biodel to Amend June 30, 2007 10-Q to Correct Non-Cash Share-Based Compensation Expense 2Biodel to Amend June 30, 2007 10-Q to Correct Non-Cash Share-Based Compensation Expense 3
(Date:11/4/2009)... Rainmakers, Inc., an intellectual property holdin...nnounced that the company has exited its "stealth"...s suite of technologies designed to leverage cutti... the past four years, the company has spent tens o...es of core--but expandable--technologies built aro...
(Date:11/4/2009)... GenVault Corporation (Carlsbad, CA) today announc... Board of Directors. Dr. Brody, the Irwin Jacobs ...claimed physician-scientist and university leader....erved as president of The Johns Hopkins University...eering and the Institute of Medicine, and is renow...
(Date:11/3/2009)...,s greatest wines are the result of a threefold sy...ing called the "terroir" -- a term often defined a...rts will discuss terroir with an emphasis on soil ...tsburgh. "Terroir: Winegrapes and the Environment...l Meetings of the American Society of Agronomy (AS...
Breaking Biology News(10 mins):Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 2Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 3Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 2Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 3Great wines come from great soils 2New Automatic cell feeding station PROcellcare for life cell imaging 9973 1New Automatic cell feeding station PROcellcare for life cell imaging 9973 2When H1N1 Hits Communication From Schools to Parents is Critical 57618 1When H1N1 Hits Communication From Schools to Parents is Critical 57618 2When H1N1 Hits Communication From Schools to Parents is Critical 57618 3More People Say Medical Conditions Make it Difficult To Find a Job or Remain Employed 57615 1More People Say Medical Conditions Make it Difficult To Find a Job or Remain Employed 57615 2
..., A novel technology for synthesising chemicals f...ust over 0.50 a litre, say German scientists. But ...way, states the research published in this month,s... Developed by scientists at the Karlsruhe Institu...nown as bioliq, and is able to produce a range of ...
..., WASHINGTON, DC In a study to be presented toda...FM) annual meeting, researchers will unveil findin...weeks have a 31 percent reduction in serious compl... Corticosteroids (ACS) steroids with no adverse si...sceptible to respiratory problems which may lead t...
..., NEW BRUNSWICK, N.J. In a paper published...chers Joachim Messing, Rmy Bruggmann, and a team o...enome of sorghum, a drought-tolerant African grass...roduce better food crops for arid regions with rap...ica. , Messing, director of the Waksman Ins...
Other Biology News:Novel technology could produce biofuel for around €0.50 a liter ($2.49 a gallon) 2Study finds 'rescue course' of antenatal steroids improves outcome in premature babies 2Sequencing of sorghum genome completed 2
Gastrointestinal Profile from Novascreen-a Caliper Life Sciences Company
...ent Clean-up Micro Kit provides a fast and simple ... X-100 and other detergents from small samples of ...y using Norgens patented protein resin as an ion e...0 g of either acidic or basic protein.A complete k...
ProteoSpin Maxi Detergent Clean Up Kit from Norgen Biotek Corporation
Enzyme Characterization Service from ARVYS Proteins, Inc.
Biology Products: